Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial Intelligence
Development and Validation of an Artificial Intelligence System for Automatic Evaluation of the Extent of Intestinal Metaplasia
1 other identifier
observational
600
1 country
1
Brief Summary
Gastric intestinal metaplasia(GIM) is an important stage in the gastric cancer(GC). With technical advance of image-enhanced endoscopy (IEE), studies have demonstrated IEE has high accuracy for diagnosis of GIM. The endoscopic grading system (EGGIM), a new endoscopic risk scoring system for GC, have been shown to accurately identify a wide range of patients with GIM. However, the high diagnostic accuracy of GIM using IEE and EGGIM assessments performed all require much experience, which limits the application of EGGIM. The investigators aim to design a computer-aided diagnosis program using deep neural network to automatically evaluate the extent of IM and calculate the EGGIM scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 8, 2022
CompletedFirst Posted
Study publicly available on registry
July 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedJuly 15, 2022
July 1, 2022
1.5 years
July 8, 2022
July 14, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
The specificity of AI model to assess the degree of intestinal metaplasia in an endoscopic picture
The specificity of AI model to assess the degree of intestinal metaplasia in an endoscopic picture
2 years
The accuracy of AI model to assess the degree of intestinal metaplasia in an endoscopic picture
The accuracy of AI model to assess the degree of intestinal metaplasia in an endoscopic picture
2 years
The sensitivity of AI model to assess the degree of intestinal metaplasia in an endoscopic picture
The sensitivity of AI model to assess the degree of intestinal metaplasia in an
2 years
Secondary Outcomes (4)
Accuracy of the experienced endoscopists to assess the degree of intestinal metaplasia
2 years
Accuracy of the inexperienced endoscopists to assess the degree of intestinal metaplasia
2 years
Inter-observer agreement among experienced endoscopists in identifying the degree of intestinal metaplasia
2 years
Inter-observer agreement among inexperienced endoscopists in identifying degree of intestinal metaplasia
2 years
Study Arms (2)
group for training the algorithm
This group of images is used for training the algorithm of the artificial intelligence
group for testing the algorithm
This group of images is used for testing the algorithm of the artificial intelligence
Eligibility Criteria
Consecutive patients who receive the IEE examination and screened that fulfill the eligibility criteria at Qilu Hospital, Shandong University will be enrolled into the study
You may qualify if:
- patients aged 18-80 years who undergo the IEE examination
You may not qualify if:
- patients with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric disorders who cannot participate in gastroscopy
- patients with previous surgical procedures on the stomach
- patients who refuse to sign the informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastrology, QiLu Hospital, Shandong University
Jinan, Shandong, 250012, China
Study Officials
- STUDY CHAIR
yanqing Li, MD, PHD
Qilu Hospital of Shandong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice President of Qilu Hospital
Study Record Dates
First Submitted
July 8, 2022
First Posted
July 15, 2022
Study Start
July 1, 2022
Primary Completion
December 30, 2023
Study Completion
December 30, 2023
Last Updated
July 15, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share